Bioadaptives BDPT
OTC BDPT
$0.00 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Bioadaptives, Inc. (BDPT) Assets (2013 - 2026)

Bioadaptives (BDPT) posted Assets of $135949.0 for Q1 2026, down 39.82% sequentially from $225901.0 in Q4 2025, and up 23.09% YoY from $110448.0 in Q1 2025.

Bioadaptives, Inc. (BDPT) Assets (2013 - 2026) Analysis & Trends

Bioadaptives has reported Assets for 13 years, with the latest figure at $135949.0 in Q1 2026.

  • Quarterly Assets rose 23.09% year-over-year to $135949.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $135949.0 (up 23.09% YoY) and the FY2025 annual result came in at $225901.0, down 13.74% from the prior year.
  • Assets fell to $135949.0 in Q1 2026 per BDPT's latest filing, from $225901.0 in the prior quarter.
  • Over five years, Assets peaked at $329302.0 in Q3 2023 and troughed at $8735.0 in Q2 2024.
  • A 5-year average of $115461.4 and a median of $87072.0 in 2022 frame the typical range for Assets.
  • The sharpest annual moves came in 2024 and 2025: Assets plunged 85.91% in 2024, then surged 3019.81% in 2025.
  • Over 5 years, Assets stood at $37314.0 in 2022, then soared by 178.71% to $103998.0 in 2023, then soared by 151.82% to $261885.0 in 2024, then fell by 13.74% to $225901.0 in 2025, then slumped by 39.82% to $135949.0 in 2026.
  • According to Business Quant data, Assets over the past three periods registered $135949.0, $225901.0, and $124360.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 135,949.00
Dec 31, 2025 225,901.00
Sep 30, 2025 124,360.00
Jun 30, 2025 272,515.00
Mar 31, 2025 110,448.00
Dec 31, 2024 261,885.00
Sep 30, 2024 46,393.00
Jun 30, 2024 8,735.00
Mar 31, 2024 58,667.00
Dec 31, 2023 103,998.00
Sep 30, 2023 329,302.00
Jun 30, 2023 48,273.00
Mar 31, 2023 13,039.00
Dec 31, 2022 37,314.00
Sep 30, 2022 29,615.00
Jun 30, 2022 69,377.00
Mar 31, 2022 87,072.00
Dec 31, 2021 148,585.00
Sep 30, 2021 178,695.00
Jun 30, 2021 135,971.00